JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCarthy, D. A.
Right arrow Articles by Nicolaides, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCarthy, D. A.
Right arrow Articles by Nicolaides, E. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 148, Issue 1, 117-122, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


AN IN VIVO ESTIMATION OF THE POTENCIES AND HALF-LIVES OF SYNTHETIC BRADYKININ AND KALLIDIN

D. A. McCarthy 1, D. E. Potter 1, and E. D. Nicolaides 1

1 Research Division, Parke, Davis & Company, Ann Arbor, Michigan

The relative vasodilating capacity of the synthetic kinins, bradykinin and kallidin, was compared in the dog autoperfused hindquarters preparation. Kallidin was found to be more potent than bradykinin in this preparation. A method utilizing this preparation was found suitable for measuring the half-life in blood of highly potent vasoactive substances which are rapidly destroyed by blood. This procedure has been applied to determine the half-life ( tfrac12) of the synthetic nonapeptide, bradykinin, and to compare it with its synthetic 1-lysyl homolog, kallidin. The tfrac12, of bradykinin (0.27 ± 0.013) remained substantially constant within the range of doses and duration of incubation in extracorporeal blood studied, while the tfrac12 of kallidin increased from 0.32 to 0.48 minute as higher initial concentrations were incubated for more prolonged periods. This suggests that the inactivation of kallidin may not follow the kinetics of unimolecular reactions. A possible explanation for this observation was that some intermediate(s) in the inactivation of kallidin had sufficient vasodilating action to contribute measurably to the vasodilatation upon which the determination of the tfrac12, depended.

Accepted on December 10, 1964




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
D. E. Casarini, M. A. Boim, R. C. R. Stella, and N. Schor
Endopeptidases (kininases) are able to hydrolyze kinins in tubular fluid along the rat nephron
Am J Physiol Renal Physiol, July 1, 1999; 277(1): F66 - F74.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.